These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 16096644

  • 21. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells.
    Masison DC, Wickner RB.
    Science; 1995 Oct 06; 270(5233):93-5. PubMed ID: 7569955
    [Abstract] [Full Text] [Related]

  • 22. Prion domain initiation of amyloid formation in vitro from native Ure2p.
    Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB.
    Science; 1999 Feb 26; 283(5406):1339-43. PubMed ID: 10037606
    [Abstract] [Full Text] [Related]

  • 23. Mutations Outside the Ure2 Amyloid-Forming Region Disrupt [URE3] Prion Propagation and Alter Interactions with Protein Quality Control Factors.
    Kumar S, Dine EA, Paddock E, Steinberg DN, Greene LE, Masison DC.
    Mol Cell Biol; 2020 Oct 13; 40(21):. PubMed ID: 32868289
    [Abstract] [Full Text] [Related]

  • 24. Structure of the prion Ure2p in protein fibrils assembled in vitro.
    Fay N, Redeker V, Savistchenko J, Dubois S, Bousset L, Melki R.
    J Biol Chem; 2005 Nov 04; 280(44):37149-58. PubMed ID: 16131495
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The [URE3] prion is not conserved among Saccharomyces species.
    Talarek N, Maillet L, Cullin C, Aigle M.
    Genetics; 2005 Sep 04; 171(1):23-34. PubMed ID: 15956663
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Structure and assembly properties of the N-terminal domain of the prion Ure2p in isolation and in its natural context.
    Bousset L, Bonnefoy J, Sourigues Y, Wien F, Melki R.
    PLoS One; 2010 Mar 22; 5(3):e9760. PubMed ID: 20339590
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Stability, folding, dimerization, and assembly properties of the yeast prion Ure2p.
    Thual C, Bousset L, Komar AA, Walter S, Buchner J, Cullin C, Melki R.
    Biochemistry; 2001 Feb 13; 40(6):1764-73. PubMed ID: 11327838
    [Abstract] [Full Text] [Related]

  • 33. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p.
    Bousset L, Redeker V, Decottignies P, Dubois S, Le Maréchal P, Melki R.
    Biochemistry; 2004 May 04; 43(17):5022-32. PubMed ID: 15109261
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The [URE3] yeast prion: from genetics to biochemistry.
    Komar AA, Melki R, Cullin C.
    Biochemistry (Mosc); 1999 Dec 04; 64(12):1401-7. PubMed ID: 10648964
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae.
    Wickner RB.
    Science; 1994 Apr 22; 264(5158):566-9. PubMed ID: 7909170
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.